International Journal of Homoeopathic Sciences

Introduction: Allergic rhinitis (AR) is a global health concern affecting quality of life. While conventional treatments are effective, they can have side effects, leading patients to seek complementary therapies. This study evaluates the effectiveness of individualized homeopathic medicine (IHM) in managing AR in a real-world setting.

Methods: A prospective, observational, single-arm study was conducted on 150 patients with a confirmed diagnosis of AR. Patients received IHM selected after a detailed case history. The primary outcome measure was the change in the Total Nasal Symptom Score (TNSS) from baseline to 6 months. Secondary outcomes included changes in the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score. Data were analyzed using paired t-tests, and effect size was calculated.
Results: A total of 150 patients (mean age 32.4±10.1 years, 58% female) completed the study. The mean TNSS decreased significantly from 11.2±2.8 at baseline to 3.8±3.1 at 6 months (p<0.001). The mean RQLQ score improved from 4.5±1.1 to 1.8±1.0 (p<0.001). 132 out of 150 patients showed marked to moderate improvement, yielding an effectiveness rate of 88.0%. No adverse events were reported.

Conclusion: Individualized homeopathic treatment was associated with a significant reduction in allergic rhinitis symptoms and a substantial improvement in quality of life in this study cohort. The observed effectiveness rate of 88% suggests that IHM is a valuable therapeutic option for AR patients. Further randomized controlled trials are warranted to confirm these findings.